3.5 Meta-analysis The included studies showed substantial heterogeneity (I 2 = 99.6%, p 0.05), supporting the conclusion of comparable efficacy and the lack of a clear doseresponse relationship
However a blood test is not mandatory to begin treatment if your symptoms and clinical history are consistent with deficiency
Compounds in the samples analyzed in 2024 were identified using a liquid chromatograph with quadrupole TOF mass spectrometer (LCMS9050-Q-TOF, Shimadzu Corporation, Kyoto, Japan)
They might do blood tests showing improvement (e.g., better red blood cell indices once B/B levels normalize)
Instability, stabilization, and formulation of liquid protein pharmaceuticals
B-12 Injection Mobile Clinic San Diego August 3, 2025 @ 11:00 am - 3:00 pm Tired of Feeling Tired